| Parameter | Score |
|---|---|
| 1. Scale | A |
| 2. Study Population | A |
| 3. Samples | A |
| 4. Measurand | B |
| 5. Pre-Analytical | A |
| 6. Replicate Analysis | B |
| 7. Steady State | B |
| 8. Outlier Analysis | A |
| 9. Normality | B |
| 10. Variance Homogeneity | C |
| 11. ANOVA | B |
| 12. CI | A |
| 13. No of Results | C |
| 14. Concentrations | A |
| 15. Total Score | C10,13 |
| Comment | insulin resistant |
| Parameter | Score |
|---|---|
| Matrix | Serum |
| Measurand | Triglycerides |
| Unit | mmol / L |
| Overall Analytical Principle Method | Enzymatic analysis - Not specified |
| Number of Subjects | 9 |
| Number of Subjects included in BV estimation | 9 |
| Ethinicity | Asian |
| Age Mean / Median | |
| Age Min | 31.0 |
| Age Max | 40.0 |
| Age SD | |
| Number of Males | 9 |
| Number of Females | |
| State of Well Being |
Healthy (excl pregnant)
|
| Diseases | |
| Study Duration Length | 3 |
| Study Duration Units | Week |
| Sampling Intervals, e.g. X sample(s) per Interval Unit | 1 |
| Interval Units | Week |
| Sampling Times | Start Time:
End Time: |
| Number of Samples | 3 |
| Average Number of Samples Used for BV Estimation | 3.0 |
| Average Number of Replicates | 1.0 |
| Estimates of CVi | 24.1 |
| Calculated Confidence Intervals of CVi | Lower: 18.31, Upper: 35.65 |
| Estimates of CVg | 45.1 |
| Calculated Confidence Intervals of CVg | Lower: 29.02, Upper: 85.00 |
| Analytical CV | 0.8 |
| Calculated Confidence Intervals of Analytical CV | Lower: 0.42, Upper: 5.03 |
| Measurand Mean | 0.7 |
| Measurand Min | |
| Measurand Max | |
| Measurand SD |